FOIA amendments signed into law in 1994 added a requirement that agencies must establish an Electronic FOIA (EFOIA) Reading Room. The EFOIA Reading Room contains such materials as certain agency manuals, specific agency policy statements, and opinions developed in the adjudication of cases.
The information you are requesting may be located in the Electronic Reading Rooms. At HHS, each major organizational component has an Electronic Reading Room. Each of our EFOIA Reading Rooms has been certified. Please check the Reading Rooms before submitting a FOIA request.
Operating Division Reading Rooms:
- Administration for Children and Families
- Administration for Community Living
- Agency for Healthcare Research and Quality
- Centers for Disease Control and Prevention & Agency for Toxic Substances and Disease Registry
- Center for Medicare & Medicaid Services
- Food and Drug Administration
- Health Resources and Services Administration
- Indian Health Service
- Office of Inspector General
- National Institutes of Health
- Substance Abuse and Mental Health Services Administration
HHS EFOIA Reading Room Material:
Final Opinions
Policy Statements
Administrative Staff Manuals
Frequently Requested Records
- Sharpless 2017 Ethics Agreements
- Examples of 2018 Title X Grant Applications
- People using assistive technology may not be able to fully access information in this file. For assistance, please contact Diane Foley 240-453-2888
- Public Comments for "Removing Barriers for Religious and Faith-Based Organizations to Participate in HHS Programs and Receive Public Funding"
- Dr. Fitzgerald Ethics Agreement
- Correspondence from the Chairman and CEO of Aetna
- Network Intrusion Attempts Database
- HHS EFOIA Reading Room Certification
- HHS FOIA Reference Materials
- Office of Inspector General Reports, Audits, etc.
- Office of the Inspector General Corporate Integrity Agreements (NOTE: includes directions on obtaining settlement agreements from the Department of Justice)
- Office of Civil Rights/ Health Insurance Portability and Accountability Act (HIPAA)
- HHS Administrative Manuals
Operation Warp Speed:
- Becton, Dickinson, & Company, Expanding Domestic Production of Needles & Syringes*
- Janssen Corp COVID-19 Vaccine Contract*
- Ology Bioservices Therapeutic*
- Pfizer, Inc. COVID-19 Vaccine Contract*
- RTI, Expanding Production of Needles and Syringes*
Proactive Releases
- Disclosure of Lobbying Activities - GlaxoSmithKline*
- GlaxoSmithKline Holdings (Americas) Inc. Small Business Subcontracting Plan*
- GSK Exhibit A Contract Data Requirements List*
- GlaxoSmithKline COVID-19 Vaccine Contract*
- AstraZeneca COVID-19 Vaccine Trials Contract*
- AstraZeneca COVID-19 Vaccine Letter Contract*
- Disclosure of Lobbying Activities - AstraZeneca*
- Astrazeneca Small Business Subcontracting Plan*
- TASSO Serology Kits - With All Mods*
- Sanofi COVID-19 Vaccine Contract*
- Regeneron Contract - Therapeutics*
- Novavax COVID-19 Vaccine Contract*
- Moderna COVID-19 Vaccine Contract*
- Monoclonal Antibody Production Contract with Eli Lilly
- Base OTA Consortium Agreement - COVID-19 Vaccine*
- Request for Prototype Projects (RPP)*
- RPP Appendix I*
- RPP Appendix II*
- RPP Appendix III*
- GRAM Contract*
- Medline OWS Contract*
- Quality Impact OWS Contract*
- Dupross OWS Contract*
- Cardinal OWS contract*
- COVID-19 Support Services Contract with BCG Federal Corp*
- Letter Contract for Vaccine Development with Novavax*
- Needles and Syringes Contract with Gold Coast Medical Supply*
- Needles and Syringes Contract with HTL-STREFA*
- Medical laboratory scientist and medical laboratory technician services contract with Patricio Enterprises*
- Contract for Domestic Industrial Base Expansion for Glass Tubing and Vials with Corning*
- Vaccine Contract with Moderna; Modifications P00001, P00002, P00003*
- COVID-19 Vaccine Components Agreement with Cytiva*
- Testing and Assays Contract with Cue Health*
- COVID-19 Therapeutic Development Agreements with Merck*
- COVID-19 Therapeutic Development Contract with Partner Therapeutics*
- Vaccine Agreement with GlaxoSmithKline, Modifications 1 and 2*
- Contract for COVID-19 related medical devices with Inovio*
- Contract for COVID-related medical countermeasure with Rigel Pharmaceuticals*
- Contract for Face Coverings for COVID-19 with Source America*
- Needles and Syringes Contract with Goldbelt 0058*
- Needles and Syringes Contract with Goldbelt 0059*
- Needles and Syringes Contract with Goldbelt 0060*
- OTA-p for COVID-related Diagnostic with New Horizons Diagnostics*
- OTA-p for COVID-related Wearable Device with Ultran*
- OTA-p for plasma based therapeutic with Grifols*
- Technical Direction Letter for Emory U Arenavirus Treatment Research
- Assay Kit Delivery Purchase Order with Biofire Defense, 0171*
- COVID-19 Lateral Flow Immunoassay Kits Contract with Maxim Biomedical*
- COVID-19 Test Kit Contract with Cepheid*
- COVID-related MCM Clinical Trial Agreement with ICON*
- COVID-related MCM Domestic Fill and Finish Capacity Reservation Contract with Ology*
- COVID-related Sample Collection Kits Contract with Cepheid*
- COVID-related convalescent plasma clinical trial agreement with John Hopkins*
- Contract for DNA Sequencing Device with Oxford Nanopore*
- Lateral Flow Immunoassay Kits Contract with ANP*
- Lateral Flow Immunoassay Kits Contract with Murtech*
- Monoclonal Antibody Production Contract with Eli Lilly*
- Needles and Syringes Contract with GoldBelt (0058), with mods 4, 5, and 6 and production schedules*
- Needles and Syringes Contract with GoldBelt (0059), with mods 5, 6, and 7 and production schedules*
- Needles and Syringes Contract with GoldBelt (0060), with mods 5, 6, 7, and 8 and production schedules*
- OT to Expand Covalescent Plasma Collection Capabilities with America's Blood Centers*
- Order for Commerical Assay Kit Delivery from Biofire Defense, 2017*
- TIA to Expand Domestic Production of Needles and Syringes with Becton and Dickinson*
- TIA to Expand Domestic Production of Needles and Syringes with Retractable Technology*
- Vaccine Development to Large Scale Manufacturing Agreement with Novavax*
- Vaccine Production Contract with Pfizer*
- COVID Tests Contract with VelocityDX*
- COVID Tests Contract with Visby Medical*
- Monoconal Antibody Production Contract to Modification 7, Eli Lilly*
- (Revised) Vaccine Agreement with Janssen Corp*
- (Revised) Vaccine Agreement with Moderna, 0100*
- Technical Direction Letter for Expanded Diagnostic Testing Device Project with Cepheid*
- Vaccine Contract with AstraZeneca*
- (Revised), Needles and Syringes Contract with Goldbelt, -0059*
- (Revised), Needles and Syringes Contract with Goldbelt, -0060*
- Diagnostic Systems Contract with Cepheid, -0046*
- Labor Support Services Order with Kalman*
- Needles and Syringes Contract with Gold Coast Medical*
- Needles and Syringes Contract with Goldbelt, -0058 (revised)*
- Part 1, Needles and Syringes Contract with Quality Impact, -0050*
- Part 2, Needles and Syringes Contract with Quality Impact, -0050*
- Technical Direction Letter for Vaccine Protoype with Sanofi*
- Technical Direction Letters and Statements of Work Antibody Platform prototype from SAB Therapeutics*
This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to foiarequest@hhs.gov. Content will be updated pending the outcome of the Section 508 review.